Identifying Factors Underlying the Discontinuation of Triptans

Completed

• Conditions: Migraine; Medication Adherence

• Registration Number: NCT00890357
• Lead Sponsor: Mayo Clinic

Brief Summary

The objective of this study is to identify reasons migraine patients stop using triptan medications for abortive headache treatment. It is hypothesized that inadequate education of the patient at the time of prescribing the triptan is positively associated with triptan discontinuation.

Detailed Description

Not available

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2009-04-27
• Study First Submitted QC: 2009-04-27
• Study First Posted: 2009-04-29
• Study Start: 2009-08
• Primary Completion: 2012-06
• Study Completion: 2012-06
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-27
• Last Update Posted: 2013-03-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 292

Inclusion Criteria

• Episodic Migraine or Chronic Migraine
• Have used a triptan medication in the prior 3 months
• Have used triptan medications for at least 1 year

Triptan Discontinuation Inclusion Criteria:

• Episodic Migraine or Chronic Migraine
• Used any triptan medication in the last 2 years
• Have not used a triptan medication in the last 6 months

Read More

Exclusion Criteria

Not provided

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

University of South Florida College of Medicine; 🇺🇸 Tampa, Florida, United States

Washington University School of Medicine; 🇺🇸 St. Louis, Missouri, United States

Cleveland Clinic Foundation; 🇺🇸 Cleveland, Ohio, United States